Minerva Neurosciences, Inc. (NERV) NASDAQ
5.55
-0.05(-0.89%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.55
-0.05(-0.89%)
Currency In USD
| Market Cap | 34.03M |
| Enterprise Value | 16.69M |
| P/E Ratio | -0.59 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -0.96 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.23 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -4.41 |
| Return On Equity | 3.6 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -293.42M |
| Net Income | -293.42M |
| Diluted EPS | -34.67 |
| Total Cash | 78.16M |
| Total Cash/Share | 1.78 |
| Total Debt | 64.96M |
| Total Debt/Equity | -0.26 |
| Current Ratio | 17.65 |
| Book Value Per Share | -5.79 |
| 52-Week Change | 260.39 |
| 52-Week High | 12.46 |
| 52-Week Low | 1.3 |
| Moving Average 50 Days | 6.45 |
| Moving Average 200 Days | 4.33 |
| Average Volume | 253,754 |
| Shares Outstanding | 6.99M |
| % Held by Institutions | 304.83 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | June 21, 2022 |